Overview

Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Reverse hybrid therapy achieves a higher eradication rate than triple therapy plus bismuth therapy remains unanswered.
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Treatments:
Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Clarithromycin
Metronidazole
Pantoprazole